What question did this study set out to answer?

To review the clinical status, delivery agents, neutron source advancements, and treatment outcomes of boron neutron capture therapy for high grade gliomas and recurrent head and neck cancers.

August 28, 2012Civil War Book ReviewOpen Access

Current status of boron neutron capture therapy of high grade gliomas and recurrent head and neck cancer

View Full Paper

Ask AI

Bookmark

Authors

RBRolf F. BarthUniversity of Chicago OHO. K. HarlingMassachusetts Institute of Technology WKW. S. KigerBeth Israel Deaconess Medical Center

Discussion

Member takes

Implication

Clinical review reports promising therapeutic potential in high grade gliomas and head and neck cancer, indicating a need for randomized trials using new accelerator neutron sources.

Key Points

To review the clinical status, delivery agents, neutron source advancements, and treatment outcomes of boron neutron capture therapy for high grade gliomas and recurrent head and neck cancers.
Reviewed the physical principles of boron-10 capture of low-energy thermal neutrons and resulting high linear energy transfer alpha and lithium-7 emissions.
Evaluated historical and modern neutron sources, focusing on reactor-based facilities and upcoming accelerator-based epithermal neutron generators.
Assessed clinical administration protocols, dosimetry, and tumor-targeting parameters for standard boron delivery agents including boronophenylalanine and sodium borocaptate.
Achieving therapeutic radiation doses with minimal normal tissue toxicity requires selective delivery agents that reach tumor boron concentrations of approximately 20 μg/g.
Clinical evaluations using boronophenylalanine and sodium borocaptate showed promising antitumor responses in both high grade glioma and recurrent head and neck cancer cohorts.
Transitioning from nuclear reactors to accelerator-based epithermal neutron sources is critical to enable broader hospital implementation and larger randomized trials.

Cite This Study

Barth et al. (2012) studied this question.

synapsesocial.com/papers/6aa94df13e7032f9260e0139 https://doi.org/10.1186/1748-717x-7-146

View Full Paper

Ask AI

Bookmark

Implication

Clinical review reports promising therapeutic potential in high grade gliomas and head and neck cancer, indicating a need for randomized trials using new accelerator neutron sources.

Current status of boron neutron capture therapy of high grade gliomas and recurrent head and neck cancer

Discussion

Member takes

Implication

Key Points

Cite This Study

Current status of boron neutron capture therapy of high grade gliomas and recurrent head and neck cancer

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider